![Context matters: On the road to responsible biosafety technologies in synthetic biology: EMBO reports: Vol 22, No 1 Context matters: On the road to responsible biosafety technologies in synthetic biology: EMBO reports: Vol 22, No 1](https://www.embopress.org/cms/asset/298fa464-3af6-43b4-90d8-98e79785d442/embr.202051227.fp.png)
Context matters: On the road to responsible biosafety technologies in synthetic biology: EMBO reports: Vol 22, No 1
![ELIXIR‐EXCELERATE: establishing Europe's data infrastructure for the life science research of the future | The EMBO Journal ELIXIR‐EXCELERATE: establishing Europe's data infrastructure for the life science research of the future | The EMBO Journal](https://www.embopress.org/cms/asset/06841fe2-13bf-4bd1-a11e-833b560e2614/embj.2020107409.fp.png)
ELIXIR‐EXCELERATE: establishing Europe's data infrastructure for the life science research of the future | The EMBO Journal
![Sketch of Adiponectin Receptors Hongkui Yu Hongqiang Ye Jie Nie Xiangyu Sun These authors contributed equally to this work. - ppt download Sketch of Adiponectin Receptors Hongkui Yu Hongqiang Ye Jie Nie Xiangyu Sun These authors contributed equally to this work. - ppt download](https://slideplayer.com/7424466/24/images/slide_1.jpg)
Sketch of Adiponectin Receptors Hongkui Yu Hongqiang Ye Jie Nie Xiangyu Sun These authors contributed equally to this work. - ppt download
![Neuroskeptic 🇺🇦 on Twitter: "A Qualitative Study of Equal Co-First Authorship https://t.co/qIbfrTImY4 Tweet by Neuro* and Skeptic* (* these authors contributed equally to this work.) https://t.co/RpvI5H6MJ9" / Twitter Neuroskeptic 🇺🇦 on Twitter: "A Qualitative Study of Equal Co-First Authorship https://t.co/qIbfrTImY4 Tweet by Neuro* and Skeptic* (* these authors contributed equally to this work.) https://t.co/RpvI5H6MJ9" / Twitter](https://pbs.twimg.com/media/EZgNH85WsAAR4tj.png)
Neuroskeptic 🇺🇦 on Twitter: "A Qualitative Study of Equal Co-First Authorship https://t.co/qIbfrTImY4 Tweet by Neuro* and Skeptic* (* these authors contributed equally to this work.) https://t.co/RpvI5H6MJ9" / Twitter
![Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors - Shi - 2021 - Liver Transplantation - Wiley Online Library Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors - Shi - 2021 - Liver Transplantation - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/6b895ee5-d556-4a2f-8d01-779403acde21/lt.25887.fp.png)
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors - Shi - 2021 - Liver Transplantation - Wiley Online Library
![MadScientist en Twitter: "Can anybody explain to me why this @sciencemagazine paper has to be cited as 'Weinreb et al. 2020' and not 'Weinreb, Rodriguez-Fraticelli et al. 2020' when it clearly says MadScientist en Twitter: "Can anybody explain to me why this @sciencemagazine paper has to be cited as 'Weinreb et al. 2020' and not 'Weinreb, Rodriguez-Fraticelli et al. 2020' when it clearly says](https://pbs.twimg.com/media/EPB_FuVX4AAMD4f.jpg)
MadScientist en Twitter: "Can anybody explain to me why this @sciencemagazine paper has to be cited as 'Weinreb et al. 2020' and not 'Weinreb, Rodriguez-Fraticelli et al. 2020' when it clearly says
![Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemic | Epidemiology & Infection Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemic | Epidemiology & Infection](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS095026882100251X/resource/name/firstPage-S095026882100251Xa.jpg)